ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,564.41
1.08%
US Tech 100
19,255.20
1.29%
Dow Jones
40,415.44
0.32%
Brent Oil
81.79
0.34%
Bitcoin
67,419.43
-0.28%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Eisai Company Ltd (PK) (ESALY)

  7. Eisai Company Ltd (PK) (ESALY) News

ESALY

Eisai (PK) (ESALY)

Eisai Company Ltd (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:ESALY
DateTimeSourceHeadlineSymbolCompany
01/09/202311:01AMDow Jones NewsTrending: Biogen, Eisai Win FDA Nod for Alzheimer's DrugUSOTC:ESALYEisai Company Ltd (PK)
01/06/20235:20PMDow Jones NewsADRs End Higher, Shell and Eisai Trade ActivelyUSOTC:ESALYEisai Company Ltd (PK)
11/30/202210:46AMDow Jones NewsTrending: Eisai/Biogen Alzheimer's Drug Shows Positive ResultsUSOTC:ESALYEisai Company Ltd (PK)
11/30/20226:05AMTipRanksBiogen and Eisai’s Alzheimer’s Drug May Pose Serious Risks, Say ResearchersUSOTC:ESALYEisai Company Ltd (PK)
09/28/20221:45PMDow Jones NewsDrug Companies Pursuing Alzheimer Treatments See Shares Rise WednesdayUSOTC:ESALYEisai Company Ltd (PK)
09/27/202210:05PMDow Jones NewsEisai Shares Indicated Sharply Higher After Trial of Experimental Drug Slows Alzheimer's ProgressionUSOTC:ESALYEisai Company Ltd (PK)
08/03/20227:48AMDow Jones NewsMerck: Two Phase 3 Keytruda Studies Miss TargetsUSOTC:ESALYEisai Company Ltd (PK)
07/05/202211:05PMDow Jones NewsEisai Shares Rise Sharply After U.S. FDA Grants Priority Review for Potential Alzheimer's DrugUSOTC:ESALYEisai Company Ltd (PK)
12/22/202110:27PMDow Jones NewsEisai Shares Fall Sharply After Japan Panel Seeks More Data for Aduhelm ReviewUSOTC:ESALYEisai Company Ltd (PK)
12/22/20218:26AMDow Jones NewsBiogen: Japan Panel Seeks Additional Data in Aducanumab ReviewUSOTC:ESALYEisai Company Ltd (PK)
12/17/20218:00AMDow Jones NewsBiogen's Alzheimer's Treatment Gets Negative CHMP OpinionUSOTC:ESALYEisai Company Ltd (PK)
11/29/20217:28AMDow Jones NewsMerck, Eisai Get Europe OK for Lenvima/Keytruda Combination in Two CancersUSOTC:ESALYEisai Company Ltd (PK)
11/11/20216:40PMDow Jones NewsBiogen, Eisai Alzheimer Treatment Shows Positive Signs in Advanced TrialUSOTC:ESALYEisai Company Ltd (PK)
10/15/20218:21AMDow Jones NewsMerck, Eisai Get CHMP Backing for Lenvima-Keytruda Combo in Two CancersUSOTC:ESALYEisai Company Ltd (PK)
01/28/20165:00PMDow Jones NewsFDA Approves Eisai's Halaven to Treat LiposarcomaUSOTC:ESALYEisai Company Ltd (PK)
09/02/20152:00AMDow Jones NewsAmgen to Help Develop Novartis's Pipeline of Alzheimer's DrugsUSOTC:ESALYEisai Company Ltd (PK)
06/09/201511:06AMThe Motley FoolObesity Drugs: Stocks to WatchUSOTC:ESALYEisai Company Ltd (PK)
04/09/20157:20PMDow Jones NewsJapanese Drug Company Eisai to Cut 25% of U.S. JobsUSOTC:ESALYEisai Company Ltd (PK)
03/28/201512:03PMThe Motley Fool5 Freakishly Expensive Cancer DrugsUSOTC:ESALYEisai Company Ltd (PK)
09/11/20148:50AMDow Jones NewsFDA Approves Orexigen's Diet Drug ContraveUSOTC:ESALYEisai Company Ltd (PK)
12/16/20135:05PMZacksPipeline Progress at Corcept - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
11/08/20135:00PMZacksArena Pharma Q3 Loss Narrower than Expected - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
06/16/201310:53PMDow Jones NewsASIA MARKETS: Japan Stocks Rebound As Asia Awaits Fed MeetingUSOTC:ESALYEisai Company Ltd (PK)
05/14/20136:02AMZacksJazz Pharma Posts Higher Y/Y Earnings - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
05/06/20137:10AMZacksArena Pharma Narrows Loss - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
04/23/20131:45PMZacksData from Novartis' SPARK - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
04/16/20132:30PMZacksBioLineRx to Start BL-8040 Study - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
04/16/20132:30PMZacksBioLineRx to Start BL-8040 Study - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
04/09/20131:55PMZacksPatients Dosed in Arena Study - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
03/08/20139:43AMZacksArena Cuts Loss, Misses Estimates - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
 Showing the most relevant articles for your search:USOTC:ESALY

Your Recent History

BIT
NSCIT2222130
Council of Europe
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved